Related Experiment Video
Updated: Aug 6, 2026

06:27
Isolation and Characterization of Exosomes from Skeletal Muscle Fibroblasts
Published on: May 16, 2020
Consistent functional properties of MSC-exosomes from different batches revealed by comparative multi-omics,
Byong Seung Cho1, Jun Ho Lee1, Kyong-Oh Shin2
1ExoCoBio Exosome Institute (EEI), ExoCoBio Inc, STE 306, 19 Gasan Digital 1-Ro, Geumcheon-Gu, Seoul, 08594, Republic of Korea.
Stem Cell Research & Therapy
|July 21, 2026
Summary
Adipose tissue-derived mesenchymal stromal cell-derived exosomes (ASC-EXOs) from three donors showed consistent therapeutic potential. These exosomes effectively reduced inflammation and improved skin conditions in preclinical models, supporting their clinical use.
Area of Science:
- Cell biology
- Biotechnology
- Immunology
Background:
- Mesenchymal stromal cell-derived exosomes (MSC-EXOs) are investigated for anti-inflammatory properties and clinical applications.
- GMP-produced MSC-exosomes may differ in molecular content, necessitating source comparison.
- Adipose tissue-derived MSC-EXOs (ASC-EXOs) are a promising therapeutic candidate.
Purpose of the Study:
- To compare ASC-EXOs from three healthy donors isolated under Good Manufacturing Practice (GMP) conditions.
- To assess the consistency of ASC-EXO characteristics and therapeutic efficacy.
- To evaluate ASC-EXOs for potential clinical applications.
Main Methods:
- Exosomes characterized by nano-tracking analysis, cryo-electron microscopy, tetraspanin profiling, and multi-omics.
- Functional assays assessed anti-inflammatory effects and collagen production in vitro.
- In vivo efficacy evaluated in a mouse model of atopic dermatitis.
Main Results:
- No significant differences in ASC-EXO yield or characteristics were observed among batches.
- Multi-omics revealed minor cargo variations but highly similar functional profiles.
- ASC-EXOs demonstrated comparable in vitro anti-inflammatory and collagen-modulating effects and in vivo efficacy in an atopic dermatitis model.
Conclusions:
- ASC-EXOs from different batches exhibit consistent therapeutic effects.
- Biological efficacy and bioinformatics analysis are crucial for MSC-EXO quality control.
- Findings support the clinical development of ASC-EXOs.

